Sodium channel blockers as neuroprotectants in neuroinflammatory disease: a double-edged sword.
Stys
Peter K
PK
D000818:Animals; D004195:Disease Models, Animal; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000188:drug therapy*; D051379:Mice; D026941:Sodium Channel Blockers / Q000009:adverse effects / Q000627:therapeutic use*
D026941:Sodium Channel Blockers